The first known case of vaccine-induced thrombotic thrombocytopenia in Australia.
作者信息
Hocking Jay, Chunilal Sanjeev D, Chen Vivien M, Brighton Tim, Nguyen James, Tan Jocelyn, Ting Stephen B, Tran Huyen
机构信息
Box Hill Hospital, Melbourne, VIC.
Monash Health, Melbourne, VIC.
出版信息
Med J Aust. 2021 Jul;215(1):19-20.e1. doi: 10.5694/mja2.51135. Epub 2021 Jun 11.
Abstract
摘要
相似文献
1
The first known case of vaccine-induced thrombotic thrombocytopenia in Australia.澳大利亚首例已知的疫苗诱导的血栓性血小板减少症病例。
Med J Aust. 2021 Jul;215(1):19-20.e1. doi: 10.5694/mja2.51135. Epub 2021 Jun 11.
2
COVID-19 vaccines and thrombosis with thrombocytopenia syndrome.COVID-19 疫苗与血栓性血小板减少综合征。
Expert Rev Vaccines. 2021 Aug;20(8):1027-1035. doi: 10.1080/14760584.2021.1949294. Epub 2021 Jul 8.
3
Thrombosis With Thrombocytopenia After the Messenger RNA-1273 Vaccine.信使核糖核酸-1273疫苗接种后出现的血栓形成伴血小板减少症
Ann Intern Med. 2021 Oct;174(10):1480-1482. doi: 10.7326/L21-0244. Epub 2021 Jun 29.
4
Microvascular manifestations revealing vaccine-induced thrombotic thrombocytopenia after COVID-19 vaccination.新冠疫苗接种后微血管表现揭示疫苗诱导的血栓性血小板减少症
J Med Vasc. 2022 Feb;47(1):36-38. doi: 10.1016/j.jdmv.2022.01.072. Epub 2022 Jan 17.
5
SARS-CoV-2 vaccine-induced prothrombotic immune thrombocytopenia: Promoting awareness to improve patient-doctor trust.严重急性呼吸综合征冠状病毒2型疫苗诱导的血栓形成性免疫性血小板减少症：提高认识以增强医患信任。
J Med Virol. 2021 Oct;93(10):5721-5723. doi: 10.1002/jmv.27176. Epub 2021 Jul 11.
6
[Guidelines on: COVID-19 Vaccine Induced Thrombosis, Bleeding, and Thrombocytopenia].[关于新型冠状病毒肺炎疫苗诱导的血栓形成、出血和血小板减少症的指南]
Acta Med Port. 2021 Aug 31;34(9):625-629. doi: 10.20344/amp.16602. Epub 2021 Jun 18.
7
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosis.新型冠状病毒肺炎疫苗诱导的免疫性血栓性血小板减少症：内脏静脉血栓形成的一个新病因
Ann Hepatol. 2021 Jul-Aug;23:100356. doi: 10.1016/j.aohep.2021.100356. Epub 2021 Apr 30.
8
Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.疑似 COVID-19 疫苗诱导（免疫性）血栓性血小板减少症的实验室检测。
Int J Lab Hematol. 2021 Aug;43(4):559-570. doi: 10.1111/ijlh.13629. Epub 2021 Jun 17.
9
COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.新型冠状病毒肺炎：严重急性呼吸综合征冠状病毒2疫苗诱导的免疫性血栓性血小板减少症
Hamostaseologie. 2021 Jun;41(3):179-182. doi: 10.1055/a-1369-3488. Epub 2021 Jun 30.
10
Adrenal haemorrhage and COVID-19 vaccine-induced immune thrombotic thrombocytopenia: correspondence.肾上腺出血与新冠疫苗诱导的免疫性血栓性血小板减少症：通信
QJM. 2022 Dec 12;115(12):875. doi: 10.1093/qjmed/hcac006.
引用本文的文献
1
Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination.新型冠状病毒2感染和新冠疫苗接种后的血液凝固及血栓形成障碍
Biomedicines. 2023 Oct 17;11(10):2813. doi: 10.3390/biomedicines11102813.
2
Heparin-Induced Thrombotic Thrombocytopenia (HITT) and Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Similar but Different.肝素诱导的血栓性血小板减少症 (HITT) 和疫苗诱导的免疫性血栓性血小板减少症 (VITT)：相似但不同。
Methods Mol Biol. 2023;2663:405-415. doi: 10.1007/978-1-0716-3175-1_26.
3
Incidence of sinus thrombosis with thrombocytopenia-A nation-wide register study.伴有血小板减少的窦血栓形成发生率：一项全国性登记研究。
PLoS One. 2023 Feb 24;18(2):e0282226. doi: 10.1371/journal.pone.0282226. eCollection 2023.
4
Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination.了解新冠病毒疫苗接种后伴有血小板减少的血栓形成综合征
NPJ Vaccines. 2022 Nov 9;7(1):141. doi: 10.1038/s41541-022-00569-8.
5
Assessment of immunological anti-platelet factor 4 antibodies for vaccine-induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients.评估澳大利亚大队列中免疫性抗血小板因子 4 抗体在疫苗诱导的血栓性血小板减少症（VITT）中的作用：一项包含 1284 例患者的多中心研究。
J Thromb Haemost. 2022 Dec;20(12):2896-2908. doi: 10.1111/jth.15881. Epub 2022 Sep 29.
6
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.接种 COVID-19 疫苗后的自身免疫和自身炎症性疾病。新病例报告和最新文献回顾。
J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24.
7
Immune Thrombocytopenia in Previously Healthy Individuals Following SARS-CoV-2 Vaccination (COVID-19 Immunization): A Descriptive Research of 70 Instances With a Focus on Biomarkers, Predictive Outcomes, and Consequences.新型冠状病毒疫苗接种（COVID-19免疫）后既往健康个体出现的免疫性血小板减少症：70例病例的描述性研究，重点关注生物标志物、预测结果和后果
Cureus. 2022 Jul 1;14(7):e26480. doi: 10.7759/cureus.26480. eCollection 2022 Jul.
8
Vaccine safety: what systems are required to ensure public confidence in vaccines?疫苗安全：需要哪些系统来确保公众对疫苗的信心？
Med J Aust. 2022 Aug 15;217(4):189-190. doi: 10.5694/mja2.51662. Epub 2022 Jul 17.
9
Understanding vaccine-induced thrombotic thrombocytopenia (VITT).了解疫苗诱导的血栓性血小板减少症（VITT）。
Intern Med J. 2022 May;52(5):717-723. doi: 10.1111/imj.15783. Epub 2022 Apr 21.
10
COVID-19, Vaccines, and Thrombotic Events: A Narrative Review.2019冠状病毒病、疫苗与血栓形成事件：一篇叙述性综述
J Clin Med. 2022 Feb 11;11(4):948. doi: 10.3390/jcm11040948.
本文引用的文献
1
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.ChAdOx1新冠疫苗接种后的血栓形成和血小板减少症
N Engl J Med. 2021 Jun 3;384(22):2124-2130. doi: 10.1056/NEJMoa2104882. Epub 2021 Apr 9.
2
COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies.COVID-19 患者常表现出高滴度非血小板活化抗 PF4/肝素 IgG 抗体。
J Thromb Haemost. 2021 May;19(5):1294-1298. doi: 10.1111/jth.15262. Epub 2021 Apr 7.
3
A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia.多中心评估当代实验室检测肝素诱导的血小板减少症的方法。
Pathology. 2021 Feb;53(2):247-256. doi: 10.1016/j.pathol.2020.07.012. Epub 2020 Oct 5.
4
High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review.大剂量静脉注射免疫球蛋白治疗和预防肝素诱导的血小板减少症：综述。
Expert Rev Hematol. 2019 Aug;12(8):685-698. doi: 10.1080/17474086.2019.1636645. Epub 2019 Jul 5.
Zotero 插件